The role of optical coherence tomography in coronary intervention

Korean Journal of Internal Medicine

Volumn 27, Issue 1, 2012, Pages 1-12

  Terashima, Mitsuyasu ^a   Kaneda, Hideaki ^b   Suzuki, Takahiko ^a  

^a Toyohashi Heart Center Toyohashi   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

Angioplasty; Coronary disease; Interventional; Optical coherence; Stents; Tomography; Ultrasonography

Indexed keywords

EVEROLIMUS; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ANGIOSCOPY; ATHEROSCLEROTIC PLAQUE; BALLOON OCCLUSION; BARE METAL STENT; CORONARY ARTERY DISEASE; CORONARY STENT; DIAGNOSTIC ACCURACY; DRUG ELUTING STENT; FOLLOW UP; FREQUENCY DOMAIN OPTICAL COHERENCE TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; STENT THROMBOSIS; TIME DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY; WOUND HEALING;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; HUMANS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; STENTS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84863379505     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2012.27.1.1     Document Type: Review

References (43)

1. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-1181.
2. Yamaguchi T, Terashima M, Akasaka T, et al. Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting. Am J Cardiol 2008;101:562-567.
3. Kataiwa H, Tanaka A, Kitabata H, et al. Head to head comparison between the conventional balloon occlusion method and the non-occlusion method for optical coherence tomography. Int J Cardiol 2011;146:186-190.
4. Prati F, Cera M, Ramazzotti V, et al. From bench to bedside: a novel technique of acquiring OCT images. Circ J 2008;72:839-843.
5. Barlis P, Schmitt JM. Current and future developments in intracoronary optical coherence tomography imaging. EuroIntervention 2009;4:529-533.
6. Takarada S, Imanishi T, Liu Y, et al. Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion. Catheter Cardiovasc Interv 2010;75:202-206.
7. Imola F, Mallus MT, Ramazzotti V, et al. Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention. Euro-Intervention 2010;6:575-581.
8. Templin C, Meyer M, Muller MF, et al. Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. Eur Heart J 2010;31:1792-1801.
9. Jang IK, Bouma BE, Kang DH, et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 2002;39:604-609.
10. Yabushita H, Bouma BE, Houser SL, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002;106:1640-1645.
11. Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial plaque by optical coherence tomography. Am J Cardiol 2006;97:1172-1175.
12. Kume T, Akasaka T, Kawamoto T, et al. Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J 2006;152:755. e1-755. e4.
13. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275.
14. Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005;111:1551-1555.
15. Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007;50:933-939.
16. Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006;97:1713-1717.
17. MacNeill BD, Jang IK, Bouma BE, et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol 2004;44:972-979.
18. Manfrini O, Mont E, Leone O, et al. Sources of error and interpretation of plaque morphology by optical coherence tomography. Am J Cardiol 2006;98:156-159.
19. Gonzalo N, Serruys PW, Okamura T, et al. Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach. Heart 2009;95:1913-1919.
20. Kawamori H, Shite J, Shinke T, et al. The ability of optical coherence tomography to monitor percutaneous coronary intervention: detailed comparison with intravascular ultrasound. J Invasive Cardiol 2010;22:541-545.
21. Terashima M, Rathore S, Suzuki Y, et al. Accuracy and reproducibility of stent-strut thickness determined by optical coherence tomography. J Invasive Cardiol 2009;21:602-605.
22. Sawada T, Shite J, Negi N, et al. Factors that influence measurements and accurate evaluation of stent apposition by optical coherence tomography: assessment using a phantom model. Circ J 2009;73:1841-1847.
23. Matsumoto D, Shite J, Shinke T, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 2007;28:961-967.
24. Katoh H, Shite J, Shinke T, et al. Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. Circ J 2009;73:1033-1037.
25. Kim JS, Jang IK, Fan C, et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial. JACC Cardiovasc Interv 2009;2:1240-1247.
26. Tanaka N, Terashima M, Rathore S, et al. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis. JACC Cardiovasc Interv 2010;3:1074-1079.
27. Guagliumi G, Sirbu V. Optical coherence tomography: high resolution intravascular imaging to evaluate vascular healing after coronary stenting. Catheter Cardiovasc Interv 2008;72:237-247.
28. Terashima M, Ito T, Katoh O, et al. Relationship between stent apposition pattern and neointimal coverage after Sirolimuseluting stent implantation: analysis by optical coherence tomography (abstract). J Am Coll Cardiol 2006;47:13B.
29. Ito T, Terashima M, Takeda Y, et al. Optical coherence tomographic analysis of neointimal stent coverage in Sirolimuseluting stent, compared with bare metal stent (abstract). J Am Coll Cardiol 2006;47:13B.
30. Kim JS, Jang IK, Kim JS, et al. Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents. Heart 2009;95:1907-1912.
31. Choi HH, Kim JS, Yoon DH, et al. Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography. Int J Cardiovasc Imaging 2011 Mar 26 [Epub]. http://dx.doi.org/10.1007/s10554-011-9849-7.
32. Gutierrez-Chico JL, van Geuns RJ, Regar E, et al. Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial. Eur Heart J 2011;32:2454-2463.
33. Takano M, Inami S, Jang IK, et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimuseluting stent three months after implantation. Am J Cardiol 2007;99:1033-1038.
34. Kubo T, Imanishi T, Kitabata H, et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. JACC Cardiovasc Imaging 2008;1:475-484.
35. Guagliumi G, Costa MA, Sirbu V, et al. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial. Circulation 2011;123:274-281.
36. Tahara S, Bezerra HG, Sirbu V, et al. Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial. Heart 2010;96:1574-1578.
37. Guagliumi G, Musumeci G, Sirbu V, et al. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv 2010;3:531-539.
38. Her AY, Lee BK, Shim JM, et al. Neointimal coverage on drugeluting stent struts crossing side-branch vessels using optical coherence tomography. Am J Cardiol 2010;105:1565-1569.
39. Gutierrez-Chico JL, Regar E, Nuesch E, et al. Delayed coverage in malapposed and side-branch struts with respect to wellapposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography. Circulation 2011;124:612-623.
40. Kume T, Akasaka T, Kawamoto T, et al. Visualization of neointima formation by optical coherence tomography. Int Heart J 2005;46:1133-1136.
41. Habara M, Terashima M, Nasu K, et al. Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: an optical coherence tomography study. Circ Cardiovasc Interv 2011;4:232-238.
42. Gonzalo N, Serruys PW, Okamura T, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009;158:284-293.
43. Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv 2010;75:961-963.